Metoclopramide Accord (Metoclopramide Hydrochloride Anhydrous)

Metoclopramide works by blocking dopamine D2 receptors in the brain’s chemoreceptor trigger zone, which suppresses the vomiting reflex. In the gastrointestinal tract it also blocks D2 receptors on smooth muscle, increasing acetylcholine release and promoting coordinated stomach contractions that speed gastric emptying.

The appropriate dose of Metoclopramide Accord is determined by the prescribing clinician based on the patient’s age, condition, and response to therapy. Dosage regimens may differ for acute nausea, postoperative use, or chronic gastroparesis, and should follow the prescriber’s instructions.

Safety data for metoclopramide in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Metoclopramide Accord, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from many antiemetics by offering both central anti‑vomiting activity and peripheral pro‑kinetic effects. Unlike serotonin antagonists, it primarily targets dopamine receptors, making it useful when nausea is related to delayed gastric emptying, but it may carry a higher risk of extrapyramidal side effects.

Metoclopramide Accord should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct light, and discard any tablets that appear discoloured or damaged.

Metoclopramide Accord is taken orally, usually with a glass of water. It may be administered with or without food, depending on the prescriber’s guidance, and the tablets should be swallowed whole, not crushed or chewed, unless otherwise instructed.

Serious risks include extrapyramidal reactions such as dystonia, tardive dyskinesia with long‑term use, neuroleptic malignant syndrome, severe depression or suicidal thoughts, seizures, and life‑threatening allergic reactions. Patients should seek immediate medical attention if they experience muscle rigidity, uncontrolled movements, fever, or severe mood changes.

Metoclopramide should be avoided in individuals with known hypersensitivity to the drug, those with a history of severe extrapyramidal disorders, patients taking MAO inhibitors, and anyone for whom the risk outweighs the benefit, such as certain pregnant or lactating women without specialist advice.